Cost-Benefit Analysis of Sleeper Replacement Strategies: Simulation Model

2000 ◽  
Vol 1713 (1) ◽  
pp. 15-21 ◽  
Author(s):  
Maree R. Lake ◽  
Luis Ferreira ◽  
Martin H. Murray
Keyword(s):  
Simulation Model ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Railway Track ◽  
Benefit Analysis ◽  
Average Life ◽  
Total Cost ◽  
Track Condition ◽  
The Cost ◽  
Clustering Patterns

A simulation model predicts the condition of a section of timber-sleepered railway track, including the clustering patterns of the defective sleepers and the cost of replacement under a given strategy. These results are used to perform a cost-benefit analysis of the different possible strategies for the replacement. For the simulation model, it is assumed that the life of a timber sleeper is represented by the Weibull distribution. User-controlled inputs include the length of track and the number of years to be simulated. Results generated from the model include the percentage of defective sleepers, the average life remaining, the number of clusters of various sizes, the number of sleepers replaced, and the total cost of the strategy. Investigation was conducted into the length of track that should be simulated. The length depends on the required reliability of the model. The simulated replacement strategies are compared on the basis of cost and resulting track condition.

scholarly journals Monitoring Measures in the Elimination of Malaria in Fujian, China: A Cost-Benefit Analysis

2020 ◽  
Author(s):  
Chun-Yan HUANG ◽  
Shan-Ying Zhang ◽  
Zhu-Yun CHEN ◽  
Han-Guo XIE ◽  
Rong OUYANG
Keyword(s):  
Health Economics ◽  
Malaria Elimination ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Social Benefits ◽  
Benefit Analysis ◽  
Fujian Province ◽  
Total Cost ◽  
Per Capita ◽  
The Cost

Abstract Background: Malaria is an insect-borne infectious disease that spreads through bites from infected Anopheles mosquitos. The disease seriously endangers human health and economic development. The study focuses on Fujian Province, China, which entered the final stage of malaria elimination stage in 2005. In order to understand the costs and benefits of malaria monitoring measures during the elimination stage, the health economics of the monitoring measures should be examined. Methods: Data on the number of cases during the malaria elimination stage (2005–2019) in Fujian Province were collected and sorted. The basic economic data were obtained from the Fujian Statistical Yearbook. Based on the fundamental theories in health economics, a cost-benefit analysis was conducted based on the data. Specifically, the cost of monitoring measures during the malaria elimination stage was calculated by economic cost and compared to the benefits, which were quantified based on economic and social benefits of the monitoring measures.Results: The total cost of monitoring measures in the malaria elimination stage was estimated at 607,878,783.36 yuan (USD 87,534,544.80). The components of the total cost were: case detection and treatment, which accounted for 66.62% of costs, health education with 13.31%, epidemic monitoring, 10.05%, supervision and assessment, 5.15%, and training and meetings took 4.87%. The total benefit of the monitoring measures in the malaria elimination stage was valued at about 116,123,417,911.81 yuan (USD 16,721,772,179.30). Direct economic benefit accounted for 22.61% of the total, while the social benefit was 77.39%. The cost-benefit analysis of the malaria elimination stage showed that the net benefit of monitoring measures was about 115,515,539,128.45 yuan (USD 16,634,237,634.50) and the benefit-cost ratio was 191.03. The monitoring cost for residents was 1.08 yuan (USD 0.16) per capita, and the benefit for residents was 206.12 yuan (USD 29.68) per capita. Conclusions: The monitoring measures conducted in the malaria elimination stage are a highly cost-effective intervention for reducing the negative impact of malaria in Fujian Province. Over the past 15 years, malaria control work has achieved excellent economic and social benefits in Fujian and the work should continue. The framework and results of this study conform to the principles of health economics and have a reference value for current malaria monitoring practices.

scholarly journals Cost and Benefit Analysis of Contract Farming

2019 ◽  
Vol 8 (1) ◽  
pp. 37-46
Author(s):  
N Harish
Keyword(s):  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Fixed Cost ◽  
Benefit Analysis ◽  
Total Income ◽  
Contract Farming ◽  
Total Cost ◽  
Before And After ◽  
Cost And Benefit Analysis ◽  
The Cost

This article focused on cost-benefit analysis of contract farming. The cost benefit analysis includes total cost, total income and profit before and after contract farming of respondents. Total cost calculated without fixed cost and with fixed cost, profit also calculated with fixed cost and without fixed cost. Contract farming is beneficial to farmers after contract farming. The total cost should be considered without fixed cost.

Hostile Takeovers and Anti-takeover Defenses in the Russian Corporate Market

2007 ◽  
pp. 70-84 ◽  
Author(s):  
E. Demidova
Keyword(s):  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Benefit Analysis ◽  
Costs And Benefits ◽  
Hostile Takeovers ◽  
Russian Market ◽  
Takeover Defenses ◽  
The Cost ◽  
European Markets

This article analyzes definitions and the role of hostile takeovers at the Russian and European markets for corporate control. It develops the methodology of assessing the efficiency of anti-takeover defenses adapted to the conditions of the Russian market. The paper uses the cost-benefit analysis, where the costs and benefits of the pre-bid and post-bid defenses are compared.

What's it Worth? Improving Surface Water Quality

1999 ◽  
Vol 40 (10) ◽  
pp. 153-159 ◽  
Author(s):  
D. H. Newsome ◽  
C. D. Stephen
Keyword(s):  
Water Quality ◽  
Surface Water ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Surface Water Quality ◽  
Control Measures ◽  
Benefit Analysis ◽  
The Cost

Many countries are investing in measures to improve surface water quality, but the investment programmes for so doing are increasingly becoming subject to cost-benefit analysis. Whilst the cost of control measures can usually be determined for individual improvement schemes, there are currently no established procedures for valuing the benefits attributable to improved surface water quality. The paper describes a methodology that has been derived that now makes this possible.

scholarly journals Economic Analysis of the Use of VCS2000 for Pork Carcass Meat Yield Grading in Korea

Animals ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 1297
Author(s):  
Juntae Kim ◽  
Hyo-Dong Han ◽  
Wang Yeol Lee ◽  
Collins Wakholi ◽  
Jayoung Lee ◽  
...  
Keyword(s):  
Economic Analysis ◽  
Net Present Value ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Feed Consumption ◽  
Cost Ratio ◽  
Benefit Analysis ◽  
Labor Costs ◽  
Meat Yield ◽  
The Cost

Currently, the pork industry is incorporating in-line automation with the aim of increasing the slaughtered pork carcass throughput while monitoring quality and safety. In Korea, 21 parameters (such as back-fat thickness and carcass weight) are used for quality grading of pork carcasses. Recently, the VCS2000 system—an automatic meat yield grading machine system—was introduced to enhance grading efficiency and therefore increase pork carcass production. The VCS2000 system is able to predict pork carcass yield based on image analysis. This study also conducted an economic analysis of the system using a cost—benefit analysis. The subsection items of the cost-benefit analysis considered were net present value (NPV), internal rate of return (IRR), and benefit/cost ratio (BC ratio), and each method was verified through sensitivity analysis. For our analysis, the benefits were grouped into three categories: the benefits of reducing labor costs, the benefits of improving meat yield production, and the benefits of reducing pig feed consumption through optimization. The cost-benefit analysis of the system resulted in an NPV of approximately 615.6 million Korean won, an IRR of 13.52%, and a B/C ratio of 1.65.

scholarly journals Beyond the Stern Review: Lessons from a risky venture at the limits of the cost–benefit analysis

2009 ◽  
Vol 68 (10) ◽  
pp. 2479-2484 ◽  
Author(s):  
Jean-Charles Hourcade ◽  
Philippe Ambrosi ◽  
Patrice Dumas
Keyword(s):  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Benefit Analysis ◽  
Stern Review ◽  
The Cost

Inferring age from otolith measurements: a review and a new approach

2004 ◽  
Vol 61 (7) ◽  
pp. 1269-1284 ◽  
Author(s):  
RIC Chris Francis ◽  
Steven E Campana
Keyword(s):  
Simulation Experiment ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
New Method ◽  
Population Parameters ◽  
Benefit Analysis ◽  
Mixture Analysis ◽  
New Approach ◽  
Individual Fish ◽  
The Cost

In 1985, Boehlert (Fish. Bull. 83: 103–117) suggested that fish age could be estimated from otolith measurements. Since that time, a number of inferential techniques have been proposed and tested in a range of species. A review of these techniques shows that all are subject to at least one of four types of bias. In addition, they all focus on assigning ages to individual fish, whereas the estimation of population parameters (particularly proportions at age) is usually the goal. We propose a new flexible method of inference based on mixture analysis, which avoids these biases and makes better use of the data. We argue that the most appropriate technique for evaluating the performance of these methods is a cost–benefit analysis that compares the cost of the estimated ages with that of the traditional annulus count method. A simulation experiment is used to illustrate both the new method and the cost–benefit analysis.

Drug costs and treatment choices: a DTB symposium

1993 ◽  
Vol 31 (11) ◽  
pp. 41-44
Keyword(s):  
Cost Benefit Analysis ◽  
Health Benefit ◽  
Cost Benefit ◽  
Drug Costs ◽  
Benefit Analysis ◽  
Treatment Choices ◽  
The Subject ◽  
The Cost ◽  
The Relationship ◽  
Service Managers

The relationship between drug costs and treatment choices was the subject of the first annual Drug and Therapeutics Bulletin symposium held in March 1993.* In a time of severe financial constraints for the NHS it is important that the money available is well spent. In the case of treatment that means the benefits must be worth the cost. There is, however, no agreed way of deciding when a particular health benefit to an individual is worth the cost to the NHS. Drug prices are easier to measure and more consistent than the prices of other treatments, and may be more amenable to cost-benefit analysis. Treatment choices are made primarily by doctors but with critical input from patients, pharmacists, nurses and health service managers. In this article we give an overview of the symposium at which speakers described ways in which drug costs and treatment choices were tackled in general practice (Ann McPherson, John Howie), in hospital (Dorothy Anderson), in clinical research and audit (Iain Chalmers, Alison Frater), by consumers (Anna Bradley), by health economists (Mike Drummond) and by government (Joe Collier). We also take into account points raised in discussion by the participants.

Sign in / Sign up

Export Citation Format

Share Document